Gastroesophageal adenocarcinoma in older adults: A comprehensive narrative review of management by the Young International Society of Geriatric Oncology
Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Baxter, Mark A. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2022transfer abstract |
|---|
| Umfang: |
13 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection - Vidana, B. ELSEVIER, 2019, cancer and aging research, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:13 ; year:2022 ; number:1 ; pages:7-19 ; extent:13 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jgo.2021.09.006 |
|---|
| Katalog-ID: |
ELV056258097 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV056258097 | ||
| 003 | DE-627 | ||
| 005 | 20230626043015.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220105s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jgo.2021.09.006 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001615.pica |
| 035 | |a (DE-627)ELV056258097 | ||
| 035 | |a (ELSEVIER)S1879-4068(21)00207-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.47 |2 bkl | ||
| 100 | 1 | |a Baxter, Mark A. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Gastroesophageal adenocarcinoma in older adults: A comprehensive narrative review of management by the Young International Society of Geriatric Oncology |
| 264 | 1 | |c 2022transfer abstract | |
| 300 | |a 13 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma. | ||
| 520 | |a Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma. | ||
| 700 | 1 | |a Marinho, Joana |4 oth | |
| 700 | 1 | |a Soto-Perez-de-Celis, Enrique |4 oth | |
| 700 | 1 | |a Rodriquenz, Maria Grazia |4 oth | |
| 700 | 1 | |a Arora, Sukeshi Patel |4 oth | |
| 700 | 1 | |a Lok, Wendy Chan Wing |4 oth | |
| 700 | 1 | |a Shih, Yung-Yu |4 oth | |
| 700 | 1 | |a Liposits, Gabor |4 oth | |
| 700 | 1 | |a O'Hanlon, Shane |4 oth | |
| 700 | 1 | |a Petty, Russell D. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Vidana, B. ELSEVIER |t Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection |d 2019 |d cancer and aging research |g Amsterdam [u.a.] |w (DE-627)ELV00348257X |
| 773 | 1 | 8 | |g volume:13 |g year:2022 |g number:1 |g pages:7-19 |g extent:13 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jgo.2021.09.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.47 |j Pathologie |x Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 13 |j 2022 |e 1 |h 7-19 |g 13 | ||
| author_variant |
m a b ma mab |
|---|---|
| matchkey_str |
baxtermarkamarinhojoanasotoperezdecelise:2022----:atospaeldncrioanleautaopeesvnraieeiwfaaeetyhyugne |
| hierarchy_sort_str |
2022transfer abstract |
| bklnumber |
44.47 |
| publishDate |
2022 |
| allfields |
10.1016/j.jgo.2021.09.006 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001615.pica (DE-627)ELV056258097 (ELSEVIER)S1879-4068(21)00207-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.47 bkl Baxter, Mark A. verfasserin aut Gastroesophageal adenocarcinoma in older adults: A comprehensive narrative review of management by the Young International Society of Geriatric Oncology 2022transfer abstract 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma. Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma. Marinho, Joana oth Soto-Perez-de-Celis, Enrique oth Rodriquenz, Maria Grazia oth Arora, Sukeshi Patel oth Lok, Wendy Chan Wing oth Shih, Yung-Yu oth Liposits, Gabor oth O'Hanlon, Shane oth Petty, Russell D. oth Enthalten in Elsevier Science Vidana, B. ELSEVIER Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection 2019 cancer and aging research Amsterdam [u.a.] (DE-627)ELV00348257X volume:13 year:2022 number:1 pages:7-19 extent:13 https://doi.org/10.1016/j.jgo.2021.09.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.47 Pathologie Medizin VZ AR 13 2022 1 7-19 13 |
| spelling |
10.1016/j.jgo.2021.09.006 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001615.pica (DE-627)ELV056258097 (ELSEVIER)S1879-4068(21)00207-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.47 bkl Baxter, Mark A. verfasserin aut Gastroesophageal adenocarcinoma in older adults: A comprehensive narrative review of management by the Young International Society of Geriatric Oncology 2022transfer abstract 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma. Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma. Marinho, Joana oth Soto-Perez-de-Celis, Enrique oth Rodriquenz, Maria Grazia oth Arora, Sukeshi Patel oth Lok, Wendy Chan Wing oth Shih, Yung-Yu oth Liposits, Gabor oth O'Hanlon, Shane oth Petty, Russell D. oth Enthalten in Elsevier Science Vidana, B. ELSEVIER Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection 2019 cancer and aging research Amsterdam [u.a.] (DE-627)ELV00348257X volume:13 year:2022 number:1 pages:7-19 extent:13 https://doi.org/10.1016/j.jgo.2021.09.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.47 Pathologie Medizin VZ AR 13 2022 1 7-19 13 |
| allfields_unstemmed |
10.1016/j.jgo.2021.09.006 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001615.pica (DE-627)ELV056258097 (ELSEVIER)S1879-4068(21)00207-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.47 bkl Baxter, Mark A. verfasserin aut Gastroesophageal adenocarcinoma in older adults: A comprehensive narrative review of management by the Young International Society of Geriatric Oncology 2022transfer abstract 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma. Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma. Marinho, Joana oth Soto-Perez-de-Celis, Enrique oth Rodriquenz, Maria Grazia oth Arora, Sukeshi Patel oth Lok, Wendy Chan Wing oth Shih, Yung-Yu oth Liposits, Gabor oth O'Hanlon, Shane oth Petty, Russell D. oth Enthalten in Elsevier Science Vidana, B. ELSEVIER Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection 2019 cancer and aging research Amsterdam [u.a.] (DE-627)ELV00348257X volume:13 year:2022 number:1 pages:7-19 extent:13 https://doi.org/10.1016/j.jgo.2021.09.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.47 Pathologie Medizin VZ AR 13 2022 1 7-19 13 |
| allfieldsGer |
10.1016/j.jgo.2021.09.006 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001615.pica (DE-627)ELV056258097 (ELSEVIER)S1879-4068(21)00207-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.47 bkl Baxter, Mark A. verfasserin aut Gastroesophageal adenocarcinoma in older adults: A comprehensive narrative review of management by the Young International Society of Geriatric Oncology 2022transfer abstract 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma. Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma. Marinho, Joana oth Soto-Perez-de-Celis, Enrique oth Rodriquenz, Maria Grazia oth Arora, Sukeshi Patel oth Lok, Wendy Chan Wing oth Shih, Yung-Yu oth Liposits, Gabor oth O'Hanlon, Shane oth Petty, Russell D. oth Enthalten in Elsevier Science Vidana, B. ELSEVIER Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection 2019 cancer and aging research Amsterdam [u.a.] (DE-627)ELV00348257X volume:13 year:2022 number:1 pages:7-19 extent:13 https://doi.org/10.1016/j.jgo.2021.09.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.47 Pathologie Medizin VZ AR 13 2022 1 7-19 13 |
| allfieldsSound |
10.1016/j.jgo.2021.09.006 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001615.pica (DE-627)ELV056258097 (ELSEVIER)S1879-4068(21)00207-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.47 bkl Baxter, Mark A. verfasserin aut Gastroesophageal adenocarcinoma in older adults: A comprehensive narrative review of management by the Young International Society of Geriatric Oncology 2022transfer abstract 13 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma. Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma. Marinho, Joana oth Soto-Perez-de-Celis, Enrique oth Rodriquenz, Maria Grazia oth Arora, Sukeshi Patel oth Lok, Wendy Chan Wing oth Shih, Yung-Yu oth Liposits, Gabor oth O'Hanlon, Shane oth Petty, Russell D. oth Enthalten in Elsevier Science Vidana, B. ELSEVIER Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection 2019 cancer and aging research Amsterdam [u.a.] (DE-627)ELV00348257X volume:13 year:2022 number:1 pages:7-19 extent:13 https://doi.org/10.1016/j.jgo.2021.09.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.47 Pathologie Medizin VZ AR 13 2022 1 7-19 13 |
| language |
English |
| source |
Enthalten in Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection Amsterdam [u.a.] volume:13 year:2022 number:1 pages:7-19 extent:13 |
| sourceStr |
Enthalten in Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection Amsterdam [u.a.] volume:13 year:2022 number:1 pages:7-19 extent:13 |
| format_phy_str_mv |
Article |
| bklname |
Pathologie |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection |
| authorswithroles_txt_mv |
Baxter, Mark A. @@aut@@ Marinho, Joana @@oth@@ Soto-Perez-de-Celis, Enrique @@oth@@ Rodriquenz, Maria Grazia @@oth@@ Arora, Sukeshi Patel @@oth@@ Lok, Wendy Chan Wing @@oth@@ Shih, Yung-Yu @@oth@@ Liposits, Gabor @@oth@@ O'Hanlon, Shane @@oth@@ Petty, Russell D. @@oth@@ |
| publishDateDaySort_date |
2022-01-01T00:00:00Z |
| hierarchy_top_id |
ELV00348257X |
| dewey-sort |
3610 |
| id |
ELV056258097 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV056258097</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626043015.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220105s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jgo.2021.09.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001615.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV056258097</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1879-4068(21)00207-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.47</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Baxter, Mark A.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Gastroesophageal adenocarcinoma in older adults: A comprehensive narrative review of management by the Young International Society of Geriatric Oncology</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">13</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marinho, Joana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Soto-Perez-de-Celis, Enrique</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rodriquenz, Maria Grazia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arora, Sukeshi Patel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lok, Wendy Chan Wing</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shih, Yung-Yu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liposits, Gabor</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">O'Hanlon, Shane</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Petty, Russell D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Vidana, B. ELSEVIER</subfield><subfield code="t">Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection</subfield><subfield code="d">2019</subfield><subfield code="d">cancer and aging research</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00348257X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:13</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:7-19</subfield><subfield code="g">extent:13</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jgo.2021.09.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.47</subfield><subfield code="j">Pathologie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">13</subfield><subfield code="j">2022</subfield><subfield code="e">1</subfield><subfield code="h">7-19</subfield><subfield code="g">13</subfield></datafield></record></collection>
|
| author |
Baxter, Mark A. |
| spellingShingle |
Baxter, Mark A. ddc 610 bkl 44.47 Gastroesophageal adenocarcinoma in older adults: A comprehensive narrative review of management by the Young International Society of Geriatric Oncology |
| authorStr |
Baxter, Mark A. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV00348257X |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.47 bkl Gastroesophageal adenocarcinoma in older adults: A comprehensive narrative review of management by the Young International Society of Geriatric Oncology |
| topic |
ddc 610 bkl 44.47 |
| topic_unstemmed |
ddc 610 bkl 44.47 |
| topic_browse |
ddc 610 bkl 44.47 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
j m jm e s p esp m g r mg mgr s p a sp spa w c w l wcw wcwl y y s yys g l gl s o so r d p rd rdp |
| hierarchy_parent_title |
Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection |
| hierarchy_parent_id |
ELV00348257X |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV00348257X |
| title |
Gastroesophageal adenocarcinoma in older adults: A comprehensive narrative review of management by the Young International Society of Geriatric Oncology |
| ctrlnum |
(DE-627)ELV056258097 (ELSEVIER)S1879-4068(21)00207-1 |
| title_full |
Gastroesophageal adenocarcinoma in older adults: A comprehensive narrative review of management by the Young International Society of Geriatric Oncology |
| author_sort |
Baxter, Mark A. |
| journal |
Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection |
| journalStr |
Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
zzz |
| container_start_page |
7 |
| author_browse |
Baxter, Mark A. |
| container_volume |
13 |
| physical |
13 |
| class |
610 VZ 44.47 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Baxter, Mark A. |
| doi_str_mv |
10.1016/j.jgo.2021.09.006 |
| dewey-full |
610 |
| title_sort |
gastroesophageal adenocarcinoma in older adults: a comprehensive narrative review of management by the young international society of geriatric oncology |
| title_auth |
Gastroesophageal adenocarcinoma in older adults: A comprehensive narrative review of management by the Young International Society of Geriatric Oncology |
| abstract |
Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma. |
| abstractGer |
Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma. |
| abstract_unstemmed |
Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
1 |
| title_short |
Gastroesophageal adenocarcinoma in older adults: A comprehensive narrative review of management by the Young International Society of Geriatric Oncology |
| url |
https://doi.org/10.1016/j.jgo.2021.09.006 |
| remote_bool |
true |
| author2 |
Marinho, Joana Soto-Perez-de-Celis, Enrique Rodriquenz, Maria Grazia Arora, Sukeshi Patel Lok, Wendy Chan Wing Shih, Yung-Yu Liposits, Gabor O'Hanlon, Shane Petty, Russell D. |
| author2Str |
Marinho, Joana Soto-Perez-de-Celis, Enrique Rodriquenz, Maria Grazia Arora, Sukeshi Patel Lok, Wendy Chan Wing Shih, Yung-Yu Liposits, Gabor O'Hanlon, Shane Petty, Russell D. |
| ppnlink |
ELV00348257X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.jgo.2021.09.006 |
| up_date |
2024-07-06T19:52:43.969Z |
| _version_ |
1803860641285406720 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV056258097</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626043015.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220105s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jgo.2021.09.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001615.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV056258097</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1879-4068(21)00207-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.47</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Baxter, Mark A.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Gastroesophageal adenocarcinoma in older adults: A comprehensive narrative review of management by the Young International Society of Geriatric Oncology</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">13</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Gastroesophageal adenocarcinoma is a disease of older adults with very poor survival rates. Its incidence has risen dramatically across the world in recent decades. Current treatment approaches for older adults are based largely on extrapolated evidence from clinical trials conducted in younger and fitter participants than those more commonly encountered in clinical practice. Understanding how to apply available evidence to our patients in the clinic setting is essential given the high morbidity of both curative and palliative treatment. This review aims to use available data to inform the management of an older adult with gastroesophageal adenocarcinoma.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marinho, Joana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Soto-Perez-de-Celis, Enrique</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rodriquenz, Maria Grazia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arora, Sukeshi Patel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lok, Wendy Chan Wing</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shih, Yung-Yu</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liposits, Gabor</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">O'Hanlon, Shane</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Petty, Russell D.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Vidana, B. ELSEVIER</subfield><subfield code="t">Differential Chemokine Responses in the Murine Brain Following Experimental West Nile Virus Infection</subfield><subfield code="d">2019</subfield><subfield code="d">cancer and aging research</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00348257X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:13</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:7-19</subfield><subfield code="g">extent:13</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jgo.2021.09.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.47</subfield><subfield code="j">Pathologie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">13</subfield><subfield code="j">2022</subfield><subfield code="e">1</subfield><subfield code="h">7-19</subfield><subfield code="g">13</subfield></datafield></record></collection>
|
| score |
7.3985834 |